Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    PMV Pharmaceuticals Inc.

    NASDAQ: PMVP · Real-Time Price · USD
    1.53
    -0.02 (-1.61%)
    At close: Aug 19, 2025, 12:07 PM

    PMV Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 40.88M 37.71M 108.3M 172.47M
    Short-Term Investments
    		 128.58M 165.35M 132.76M 124.7M
    Long-Term Investments
    		 13.84M 25.5M 2.5M 16.91M
    Other Long-Term Assets
    		 235K 190K 313K 221K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 6.2M 4.35M 5.95M 822K
    Total Current Assets
    		 175.66M 207.41M 247.01M 301.29M
    Property-Plant & Equipment
    		 1.55M 19.05M 20.49M 13.15M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 15.63M 44.74M 23.3M 30.28M
    Total Assets
    		 191.29M 252.15M 270.31M 331.57M
    Account Payables
    		 6.58M 3.24M 3M 3.19M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 352K n/a 528K 403K
    Other Current Liabilities
    		 5M 4.5M 3.88M 4.43M
    Total Current Liabilities
    		 14.37M 14.03M 10.83M 12.22M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 838K 12.43M 13.45M 10.79M
    Total Liabilities
    		 15.21M 26.46M 24.28M 23.01M
    Total Debt
    		 1.19M 13.29M 13.98M 11.19M
    Common Stock
    		 n/a n/a n/a n/a
    Retained Earnings
    		 -368.71M -310M -241.04M -167.73M
    Comprehensive Income
    		 139K 224K -445K -78K
    Shareholders Equity
    		 176.08M 225.69M 246.03M 308.56M
    Total Investments
    		 142.42M 190.86M 135.25M 141.61M

    Add to Watchlist